Drug Search Results
More Filters [+]

BR-03

Alternative Names: br-03, br03, br 03
Latest Update: 2024-04-30
Latest Update Note: PubMed Publication

Product Description

Bifidobacteria Probiotics Bifidobacterium Breve for Intestinal Bacterial Colonization and in the Prevention and/or Reduction of the Incidence of Colics in Infants (Sourced from: https://clinicaltrials.gov/ct2/history/NCT03219931?V_2=View)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Azienda Ospedaliero Universitaria Maggiore della Carita
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for BR-03

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Colic|Pediatric Obesity

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ACTRN12622000153718

N/A

Active, not recruiting

Respiratory Tract Infections

2023-02-10

BIFI-OBESE

P4

Completed

Pediatric Obesity

2017-10-30

NEOBIFI

P4

Completed

Colic

2017-07-31

Recent News Events